A Rational Approach to Personalized Cancer Treatment - with Dale Atkinson and Dr Hari Kuhan

Dale Atkinson is the founder of Clear Signal Partners, a healthcare consultancy that audits the patient experience from the outside in. His flagship methodology – the Patient Trust Audit – puts him through a client’s patient journey as a real prospective patient, with no insider knowledge, and reports back exactly where trust breaks down and what it’s costing them.

What makes Dale’s perspective unusual is where it comes from. He spent nearly two decades in compliance, governance, and financial crime across HSBC, Wellington Management, Schroders, and Deutsche Bank – chairing committees, running global teams, and building trust frameworks inside regulated institutions. In October 2024, he was diagnosed with Stage IV oesophageal cancer – inoperable, incurable, given less than a year. He found himself on the other side of a trust system, and the gaps were worse than anything he’d seen in financial services.

Since diagnosis, Dale has spent nearly half a million pounds navigating private healthcare alongside NHS treatment, building his own integrative protocol, and speaking to hundreds of patients with similar experiences. That combination – regulated governance professional, Stage IV cancer patient, and active private healthcare consumer – is the lens through which Clear Signal Partners operates. No one else is auditing healthcare trust from that intersection.